LakeShore Biopharma
About:
LakeShore Biopharma is a global medical company that develops and manufactures human used vaccines and immune products..
Website: https://en.lakeshorebio.com/
Twitter/X: YSBiopharma
Top Investors: OrbiMed, F-Prime Capital, Hillhouse Investment, Eight Roads Ventures, Adjuvant Capital
Description:
LakeShore Biopharma is a global, fully integrated medical company engaged in discovering, developing and commercializing innovative biotherapeutics for cancers and infectious diseases using our novel PIKA® immunomodulating technology. PIKA technology augments both innate and adaptive immune responses through the TLR3, RIG-I and MDA5 pathways. Products in clinical development include YS-ON-001 for the treatment of advanced solid tumors, YS-HBV-001 hepatitis B vaccine and the PIKA rabies vaccine for accelerated protection against rabies infection.
$211M
$100M to $500M
Hong Kong, Hong Kong Island, Hong Kong
2002-01-01
lakes_hongkong(AT)lakeshorebio.com
Yi Zhang
501-1000
2024-02-09
Public
© 2025 bioDAO.ai